Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2009-04-03 Major Shareholding Noti…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2009
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for a specific instrument (Aktie SE0000454746) by a holder (Andra AP-fonden). It explicitly states the 'Reason for major shareholding notification Sell' and shows the 'Before the transaction' and 'After the transaction' share quantities, resulting in a percentage change below the 5% limit. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2009-04-03 English
AGM Information 2009
AGM Information Classification · 100% confidence The document is titled "KALLELSE TILL ÅRSSTÄMMA I BIOTAGE AB" which translates to "NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB". It details the date, time, location, registration procedures, agenda items (including election of directors, approval of remuneration guidelines, and authorization for share issues/repurchases), and proposals for resolutions to be voted upon at the meeting. This content perfectly matches the definition of materials related to an Annual General Meeting (AGM). The specific code for AGM materials is AGM-R.
2009-03-27 Swedish
AGM Information 2009
AGM Information Classification · 99% confidence The document is explicitly titled "NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB" and details the date, location, procedures for shareholder participation, the proposed agenda, and specific resolutions to be voted upon (e.g., election of directors, appropriation of earnings, authorization for share issuance). This content is the core material used to inform shareholders and solicit their votes for the Annual General Meeting (AGM). While it contains elements that might appear in other filings (like dividend proposals or compensation guidelines), the overarching context is the formal notice and materials for the AGM. This aligns perfectly with the definition of AGM Information (AGM-R). It is not a full 10-K, an earnings release (ER), or a proxy statement (PSI), but rather the notice convening the meeting itself.
2009-03-27 English
Regulatory Filings 2009
Regulatory Filings Classification · 95% confidence The document is a press release dated January 22, 2009, announcing a strategic collaboration between Biotage AB and MultiSynTech GmbH regarding peptide synthesis systems and distribution rights. This type of announcement, detailing a business development, partnership, or strategic move that is not a standard periodic financial report (like 10-K or IR) or a specific corporate action (like dividend or share issue), typically falls under general regulatory announcements or news releases. Since it is a specific business development announcement and not a standard SEC filing form, and it doesn't fit clearly into categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate classification is the general regulatory/news category, RNS, as it is a public announcement of material business information.
2009-02-17 Swedish
Regulatory Filings 2009
Regulatory Filings Classification · 95% confidence The document is a press release dated February 17, 2009, announcing a strategic agreement between Biotage AB and MultiSynTech GmbH regarding distribution rights and a joint development project in the peptide synthesis business. This announcement details a business development/partnership rather than reporting financial results (ER, IR, 10-K), management changes (MANG), or capital structure changes (CAP, SHA). It is a specific business transaction announcement. Since there is no specific category for 'Business Development' or 'Partnership Announcement', and it is not a regulatory filing in the traditional sense (like a 10-K or DVA), the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements that don't fit the highly specific financial or governance codes. The document length is short (3296 chars), but it is the primary content, not an announcement *of* another report, so RPA is not appropriate.
2009-02-17 English
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 95% confidence The document is a 'Year-end report 2008' covering the period January-December 2008. It contains comprehensive financial statements (Consolidated Income Statements), detailed management commentary on business performance, segment analysis (Discovery Chemistry and Biosystems), and financial highlights. It is a substantive financial report for a period shorter than a full fiscal year (in the context of a year-end release, it functions as the final quarterly/interim report). It is not a mere announcement (RPA) or a simple earnings release (ER) as it provides extensive financial tables and detailed analysis. FY 2008
2009-02-10 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.